Anheuser-Busch InBev SA/NV (NYSE:BUD) Receives Buy Rating from UBS Group

Anheuser-Busch InBev SA/NV (NYSE:BUD)‘s stock had its “buy” rating restated by equities researchers at UBS Group in a research note issued to investors on Tuesday,MarketScreener reports.

A number of other research firms have also issued reports on BUD. SBG Securities lowered shares of Anheuser-Busch InBev SA/NV to a “hold” rating in a research note on Monday, March 2nd. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Anheuser-Busch InBev SA/NV in a research note on Monday, June 1st. Royal Bank Of Canada reiterated a “buy” rating on shares of Anheuser-Busch InBev SA/NV in a report on Tuesday, May 5th. The Goldman Sachs Group reissued a “buy” rating on shares of Anheuser-Busch InBev SA/NV in a report on Thursday, May 7th. Finally, Berenberg Bank reaffirmed a “buy” rating on shares of Anheuser-Busch InBev SA/NV in a research note on Friday, June 5th. Eleven research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat, Anheuser-Busch InBev SA/NV currently has a consensus rating of “Moderate Buy” and an average target price of $91.94.

Anheuser-Busch InBev SA/NV Trading Down 0.2%

Shares of BUD opened at $83.70 on Tuesday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.57 and a current ratio of 0.72. The stock has a 50-day moving average price of $79.92 and a 200 day moving average price of $74.11. The company has a market capitalization of $163.26 billion, a P/E ratio of 22.88, a P/E/G ratio of 1.38 and a beta of 0.59. Anheuser-Busch InBev SA/NV has a one year low of $56.97 and a one year high of $85.56.

Anheuser-Busch InBev SA/NV (NYSE:BUD) last posted its quarterly earnings results on Tuesday, March 31st. The consumer goods maker reported $0.97 EPS for the quarter. Anheuser-Busch InBev SA/NV had a return on equity of 16.34% and a net margin of 11.90%.The business had revenue of $15.27 billion during the quarter. Sell-side analysts forecast that Anheuser-Busch InBev SA/NV will post 4.32 EPS for the current fiscal year.

Hedge Funds Weigh In On Anheuser-Busch InBev SA/NV

A number of large investors have recently made changes to their positions in BUD. Parallel Advisors LLC lifted its stake in shares of Anheuser-Busch InBev SA/NV by 12.0% in the 1st quarter. Parallel Advisors LLC now owns 6,626 shares of the consumer goods maker’s stock valued at $460,000 after purchasing an additional 708 shares during the last quarter. Segall Bryant & Hamill LLC bought a new position in Anheuser-Busch InBev SA/NV during the first quarter valued at about $283,000. Western Wealth Management LLC bought a new stake in shares of Anheuser-Busch InBev SA/NV during the 1st quarter worth about $36,000. EverSource Wealth Advisors LLC increased its holdings in shares of Anheuser-Busch InBev SA/NV by 51.0% during the 1st quarter. EverSource Wealth Advisors LLC now owns 4,462 shares of the consumer goods maker’s stock valued at $310,000 after acquiring an additional 1,508 shares during the last quarter. Finally, Maverick Capital Ltd. increased its holdings in shares of Anheuser-Busch InBev SA/NV by 42.1% during the 1st quarter. Maverick Capital Ltd. now owns 51,020 shares of the consumer goods maker’s stock valued at $3,539,000 after acquiring an additional 15,122 shares during the last quarter. Institutional investors and hedge funds own 5.53% of the company’s stock.

Anheuser-Busch InBev SA/NV Company Profile

Anheuser-Busch InBev SA/NV (NYSE: BUD) is a multinational brewing company headquartered in Leuven, Belgium. It is one of the world’s largest brewers and is primarily engaged in the production, distribution and marketing of beer and related beverages. The company’s operations span brewing, packaging, logistics and retail/customer sales support, serving a broad set of channels from on-premise hospitality to retail and e-commerce.

AB InBev’s portfolio includes a mix of global, regional and local beer brands across mainstream, premium, craft and non-alcoholic categories.